SFM
PMVP icon

Sphera Funds Management’s PMV Pharmaceuticals PMVP Stock Holding History

Sphera Funds Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-187,800
Closed -$1.18M – 98
2023
Q2 		$1.18M Hold
187,800
– – 0.18% 83
2023
Q1 		$896K Hold
187,800
– – 0.15% 71
2022
Q4 		$1.63M Hold
187,800
– – 0.35% 45
2022
Q3 		$2.23M Hold
187,800
– – 0.31% 54
2022
Q2 		$2.68M Buy
+187,800
New +$2.73M 0.29% 36
2022
Q1 		– Sell
-190,525
Closed -$4.4M – 89
2021
Q4 		$4.4M Hold
190,525
– – 0.48% 57
2021
Q3 		$5.68M Buy
190,525
+106,451
+127% +$3.4M 0.48% 63
2021
Q2 		$2.87M Buy
84,074
+40,718
+94% +$1.36M 0.19% 95
2021
Q1 		$1.43M Buy
+43,356
New +$1.71M 0.11% 134

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's PMVP Position: Q3 2023 in Review

Sphera Funds Management sold out of PMV Pharmaceuticals (PMVP) in Q3 2023, closing a stake of 187,800 shares — an estimated $1.18M sold.

Sphera Funds Management first reported a position in PMVP in Q1 2021 and held it in 9 quarters. The position peaked at $5.68M in Q3 2021. 104 funds tracked by Wall St. Rank hold PMVP as of Q3 2023.

  • Sphera Funds Management reported no remaining PMV Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Sphera Funds Management sold 187,800 PMV Pharmaceuticals shares in Q3 2023, an estimated $1.18M.
  • Sphera Funds Management first reported a position in PMV Pharmaceuticals in Q1 2021 and held it in 9 quarters.
  • Sphera Funds Management's PMV Pharmaceuticals position peaked at $5.68M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2023.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.